Literature DB >> 18033028

[Neurological presentations of lysosomal diseases in adult patients].

F Sedel1, J-C Turpin, N Baumann.   

Abstract

Lysosomal diseases represent a large group of genetic storage disorders characterized by a defect in the catabolism of complex molecules within the lysosome. Effective treatments are now possible for some of them given progresses in bone-marrow transplantation, enzyme replacement therapy and substrate reduction therapy. Neurologists and psychiatrists are concerned by these diseases because they can present in adolescence or adulthood with progressive neuropsychiatric signs. Here we focus on late-onset clinical forms which can be met in an adult neurology or psychiatric department. Lysosomal diseases were classified into 3 groups: (1) leukodystrophies (metachromatic leukodystrophy, Krabbe's disease and Salla's disease); (2) Neurodegenerative or psychiatric-like diseases (GM1 and GM2 gangliosidoses, Niemann Pick type C disease, sialidosis type I, ceroid-lipofuscinosis, mucopolysaccharidosis type III); (3) multisystemic diseases (Gaucher's disease, Fabry's disease, alpha and B mannosidosis, Niemann Pick disease type B, fucosidosis, Schindler/Kanzaki disease, and mucopolysaccharidosis type I and II. We propose a diagnostic approach guided by clinical examination, brain MRI, electrodiagnostic studies and abdominal echography.

Entities:  

Mesh:

Year:  2007        PMID: 18033028     DOI: 10.1016/s0035-3787(07)92635-1

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  3 in total

1.  Adult-onset painful axonal polyneuropathy caused by a dominant NAGLU mutation.

Authors:  Martine Tétreault; Michael Gonzalez; Marie-Josée Dicaire; Pierre Allard; Kalle Gehring; Diane Leblanc; Nadine Leclerc; Ronald Schondorf; Jean Mathieu; Stephan Zuchner; Bernard Brais
Journal:  Brain       Date:  2015-03-28       Impact factor: 13.501

2.  Genome-wide prioritization of disease genes and identification of disease-disease associations from an integrated human functional linkage network.

Authors:  Bolan Linghu; Evan S Snitkin; Zhenjun Hu; Yu Xia; Charles Delisi
Journal:  Genome Biol       Date:  2009-09-03       Impact factor: 13.583

Review 3.  Psychiatric manifestations in cerebrotendinous xanthomatosis.

Authors:  M J Fraidakis
Journal:  Transl Psychiatry       Date:  2013-09-03       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.